ReviewThe world journal of men's health2020

Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?

Geoffrey HackettPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.